{"id":"https://openalex.org/W3004635486","doi":"https://doi.org/10.1200/jco.2020.38.4_suppl.tps599","title":"A phase II clinical trial of the phosphatidylserine targeting antibody, bavituximab, in combination with pembrolizumab in patients with advanced hepatocellular carcinoma.","display_name":"A phase II clinical trial of the phosphatidylserine targeting antibody, bavituximab, in combination with pembrolizumab in patients with advanced hepatocellular carcinoma.","publication_year":2020,"publication_date":"2020-02-01","ids":{"openalex":"https://openalex.org/W3004635486","doi":"https://doi.org/10.1200/jco.2020.38.4_suppl.tps599","mag":"3004635486"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.4_suppl.tps599","doi":"https://doi.org/10.1200/jco.2020.38.4_suppl.tps599","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.4_suppl.tps599","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014809735","display_name":"Muhammad Shaalan Beg","orcid":"https://orcid.org/0000-0002-3754-6627","observed_orcids":["https://orcid.org/0000-0002-3754-6627"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Muhammad Shaalan Beg","raw_affiliation_strings":["The University of Texas Southwestern Medical Center, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas Southwestern Medical Center, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068560690","display_name":"Hao Zhu","orcid":"https://orcid.org/0000-0002-8417-9698","observed_orcids":["https://orcid.org/0000-0002-8417-9698","https://orcid.org/0009-0005-1863-978X"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hao Zhu","raw_affiliation_strings":["The University of Texas Southwestern Medical Center, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas Southwestern Medical Center, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017798169","display_name":"David Hsieh","orcid":"https://orcid.org/0000-0002-5428-3494","observed_orcids":["https://orcid.org/0000-0002-5428-3494"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Hsieh","raw_affiliation_strings":["The University of Texas Southwestern Medical Center, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas Southwestern Medical Center, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086948150","display_name":"Syed Mohammad Ali Kazmi","orcid":"https://orcid.org/0000-0002-3367-367X","observed_orcids":["https://orcid.org/0000-0002-3367-367X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Syed Mohammad Ali Kazmi","raw_affiliation_strings":["San Juan Onc Assoc, Farmington, NM;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Juan Onc Assoc, Farmington, NM;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014365804","display_name":"Aravind Raj Sanjeevaiah","orcid":"https://orcid.org/0000-0001-7742-1442","observed_orcids":["https://orcid.org/0000-0001-7742-1442"]},"institutions":[{"id":"https://openalex.org/I2802494405","display_name":"Alaska Native Medical Center","ror":"https://ror.org/02bg8cb41","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802494405"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aravind Sanjeevaiah","raw_affiliation_strings":["Alaska Native Medical Center, Anchorage, AK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alaska Native Medical Center, Anchorage, AK;","institution_ids":["https://openalex.org/I2802494405"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014214683","display_name":"Amit G. Singal","orcid":"https://orcid.org/0000-0002-1172-3971","observed_orcids":["https://orcid.org/0000-0002-1172-3971"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amit G. Singal","raw_affiliation_strings":["The University of Texas Southwestern Medical Center, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas Southwestern Medical Center, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049423872","display_name":"Radhika Kainthla","orcid":"https://orcid.org/0000-0003-1636-2113","observed_orcids":["https://orcid.org/0000-0003-1636-2113"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Radhika Kainthla","raw_affiliation_strings":["The University of Texas Southwestern Medical Center, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas Southwestern Medical Center, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046425532","display_name":"Leticia Khosama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leticia Khosama","raw_affiliation_strings":["The University of Texas Southwestern Medical Center, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas Southwestern Medical Center, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020636445","display_name":"Kimberli Crane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberli Crane","raw_affiliation_strings":["University of Texas Southwestern Medical Center, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Southwestern Medical Center, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089104361","display_name":"Rolf A. Brekken","orcid":"https://orcid.org/0000-0003-2704-2377","observed_orcids":["https://orcid.org/0000-0003-2704-2377"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rolf A. Brekken","raw_affiliation_strings":["Division of Surgical Oncology Department of Surgery, Hamon Center for Therapeutic Oncology Research, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Surgical Oncology Department of Surgery, Hamon Center for Therapeutic Oncology Research, Dallas, TX;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085283718","display_name":"Adam Charles Yopp","orcid":"https://orcid.org/0000-0002-5887-5315","observed_orcids":["https://orcid.org/0000-0002-5887-5315"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Charles Yopp","raw_affiliation_strings":["Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX;","institution_ids":["https://openalex.org/I867280407"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"4_suppl","first_page":"TPS599","last_page":"TPS599"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bavituximab","display_name":"bavituximab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9620000123977661},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.8539999723434448},{"id":"https://openalex.org/keywords/phosphatidylserine","display_name":"phosphatidylserine","score":0.9150000214576721},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.578000009059906},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8180000185966492},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6299999952316284},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.7870000004768372},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.7879999876022339},{"id":"https://openalex.org/keywords/pharmacodynamic-markers","display_name":"pharmacodynamic biomarkers","score":0.7570000290870667},{"id":"https://openalex.org/keywords/advanced-liver-cancer","display_name":"advanced liver cancer","score":0.5759999752044678},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.37299999594688416},{"id":"https://openalex.org/keywords/exosomes","display_name":"exosomes","score":0.38499999046325684},{"id":"https://openalex.org/keywords/tumor-vasculature","display_name":"tumor vasculature","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9099745750427246},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7602410316467285},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.6248742341995239},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5599220395088196},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.468217134475708},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.45651933550834656},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.45231714844703674},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38696929812431335},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36876770853996277},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2989826798439026},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2297775149345398}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.4_suppl.tps599","doi":"https://doi.org/10.1200/jco.2020.38.4_suppl.tps599","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.4_suppl.tps599","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392645726","https://openalex.org/W4285745794","https://openalex.org/W3203280453","https://openalex.org/W4229485830","https://openalex.org/W4317877657","https://openalex.org/W2243707214","https://openalex.org/W2969756092","https://openalex.org/W2268435941","https://openalex.org/W2035466486","https://openalex.org/W3005038730"],"abstract_inverted_index":{"TPS599":[0],"Background:":[1],"Phosphatidylserine":[2],"(PS)":[3],"is":[4,21,54,86,107,122,136,216,234],"an":[5,67],"immunosuppressive":[6],"lipid":[7],"segregated":[8],"to":[9,23,61,78,235,247,274,286],"the":[10,14,24,28,43,74,88,94,152,187,237,249,290,301],"inner":[11],"leaflet":[12,26],"of":[13,17,27,90,242,255,265,300],"plasma":[15,29],"membrane":[16,30],"normal":[18],"cells.":[19],"PS":[20,56,62],"externalized":[22],"outer":[25],"on":[31],"cells":[32,39],"that":[33,59],"line":[34],"tumor":[35,38,44,75],"blood":[36,269],"vessels,":[37],"and":[40,93,150,175,202,209,252,263,268],"exosomes":[41],"in":[42,98],"microenvironment":[45,77],"creating":[46],"a":[47,55,108,307],"specific":[48],"target":[49],"for":[50,115,125,134,276],"anticancer":[51],"treatments.":[52],"Bavituximab":[53,71],"targeting":[57],"antibody":[58],"binds":[60],"via":[63],"\u03b22":[64],"glycoprotein-1":[65],"(\u03b22GP1),":[66],"abundant":[68],"serum":[69],"glycoprotein.":[70],"can":[72],"modulate":[73],"immune":[76,81],"promote":[79],"anti-tumor":[80],"activity.":[82],"This":[83,106],"clinical":[84,113,256],"trial":[85,114,327],"evaluating":[87],"effect":[89],"combining":[91],"bavituxumab":[92],"checkpoint":[95],"inhibitor":[96],"pembrolizumab":[97],"patients":[99,116,293,304,314],"with":[100,117],"advanced":[101],"hepatocellular":[102],"carcinoma":[103],"(HCC).":[104],"Methods:":[105],"single":[109],"arm":[110],"phase":[111],"2":[112,197],"histologically":[118],"confirmed":[119],"HCC":[120,135],"which":[121],"not":[123],"eligible":[124],"curative":[126],"and/or":[127],"loco-regional":[128],"therapy.":[129,243],"No":[130],"prior":[131],"systemic":[132],"therapy":[133],"allowed.":[137],"Patients":[138],"should":[139],"be":[140,284,316,320],">":[141],"18":[142],"years,":[143],"have":[144,305],"Child-Pugh":[145],"Score":[146],"A,":[147],"ECOG":[148],"0-1":[149],"meet":[151],"following":[153],"laboratory":[154],"criteria:":[155],"total":[156],"bilirubin":[157],"\u2264":[158,161],"2.0,":[159],"INR":[160],"1.7;":[162],"Hgb":[163],"\u2265":[164,173,177],"8.5":[165],"g/dl;":[166],"AST,":[167],"ALT":[168],"\u22645":[169],"times":[170],"ULN;":[171],"platelet":[172],"50,000/mm3;":[174],"albumin":[176],"2.5":[178],"g/dl.":[179],"Major":[180],"exclusion":[181],"criteria":[182],"include":[183],"thromboembolic":[184],"event":[185],"within":[186,196],"last":[188],"6":[189,260],"months,":[190,198],"clinically":[191],"evident":[192],"ascites,":[193],"GI":[194],"bleeding":[195],"uncontrolled":[199],"hypertension,":[200],"HIV":[201],"autoimmune":[203],"disease":[204],"(except":[205],"DM1,":[206],"childhood":[207],"allergies":[208],"thyroid":[210],"abnormalities":[211],"if":[212],"adequately":[213],"controlled.":[214],"Dosing":[215],"as":[217],"follows:":[218],"Bavituximab:":[219],"3":[220,229,297],"mg/kg":[221],"IV":[222,227],"weekly,":[223],"pembrolizumab:":[224],"200":[225],"mg":[226],"every":[228],"weeks.":[230],"The":[231],"primary":[232],"objective":[233],"determine":[236,248],"overall":[238],"response":[239],"rate":[240],"(ORR)":[241],"Secondary":[244],"objectives":[245],"are":[246,271,294],"safety,":[250],"tolerability":[251],"other":[253],"measures":[254],"efficacy":[257],"(overall":[258],"survival,":[259],"month":[261],"PFS,":[262],"duration":[264],"response).":[266],"Tumor":[267],"samples":[270],"being":[272],"collected":[273],"assess":[275],"pharmacodynamic":[277],"biomarkers.":[278],"A":[279],"minimax":[280],"two-stage":[281],"method":[282],"will":[283,315,319],"used":[285],"analyze":[287],"ORR":[288,318],"after":[289],"first":[291,302],"15":[292,303],"accrued.":[295],"If":[296],"or":[298,309],"more":[299],"either":[306],"complete":[308],"partial":[310],"response,":[311],"13":[312],"additional":[313],"enrolled.":[317],"analyzed":[321],"by":[322],"RECIST":[323],"1.1":[324],"criteria.":[325],"Clinical":[326],"information:":[328],"NCT03519997.":[329]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2020-02-14T00:00:00"}